

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein K6-linked ubiquitination (GO:0085020) | 5.38373884 |
| 2 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 4.86590370 |
| 3 | isotype switching (GO:0045190) | 4.86590370 |
| 4 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 4.86590370 |
| 5 | DNA deamination (GO:0045006) | 4.81355667 |
| 6 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.68913245 |
| 7 | cellular extravasation (GO:0045123) | 4.46026539 |
| 8 | positive regulation of interleukin-12 production (GO:0032735) | 4.26849080 |
| 9 | regulation of immunoglobulin secretion (GO:0051023) | 4.13287732 |
| 10 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.90476489 |
| 11 | positive regulation of T cell migration (GO:2000406) | 3.80705727 |
| 12 | response to peptidoglycan (GO:0032494) | 3.80379606 |
| 13 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.69694755 |
| 14 | defense response to protozoan (GO:0042832) | 3.69167922 |
| 15 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 3.63524943 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.63512104 |
| 17 | autophagic vacuole fusion (GO:0000046) | 3.57313371 |
| 18 | artery development (GO:0060840) | 3.56618106 |
| 19 | proline transport (GO:0015824) | 3.48565480 |
| 20 | neutrophil mediated immunity (GO:0002446) | 3.47505573 |
| 21 | regulation of interleukin-12 production (GO:0032655) | 3.47038267 |
| 22 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.46174733 |
| 23 | regulation of T cell migration (GO:2000404) | 3.41876855 |
| 24 | somatic diversification of immunoglobulins (GO:0016445) | 3.32618897 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.30087446 |
| 26 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.23625298 |
| 27 | regulation of translation in response to stress (GO:0043555) | 3.22602262 |
| 28 | N-acetylglucosamine metabolic process (GO:0006044) | 3.22204897 |
| 29 | positive regulation of lymphocyte migration (GO:2000403) | 3.20334652 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.19883607 |
| 31 | regulation of chromatin silencing (GO:0031935) | 3.15302016 |
| 32 | response to protozoan (GO:0001562) | 3.12890430 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.10163386 |
| 34 | negative T cell selection (GO:0043383) | 3.09270319 |
| 35 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.09154330 |
| 36 | organelle membrane fusion (GO:0090174) | 3.05802178 |
| 37 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.04756308 |
| 38 | positive regulation of viral genome replication (GO:0045070) | 3.02664333 |
| 39 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.02011041 |
| 40 | somite development (GO:0061053) | 3.00125462 |
| 41 | opioid receptor signaling pathway (GO:0038003) | 2.99166745 |
| 42 | N-acetylneuraminate metabolic process (GO:0006054) | 2.97703138 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.92938529 |
| 44 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.92844377 |
| 45 | regulation of neutrophil chemotaxis (GO:0090022) | 2.92806130 |
| 46 | regulation of neutrophil migration (GO:1902622) | 2.92806130 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 2.92568481 |
| 48 | regulation of Rac protein signal transduction (GO:0035020) | 2.91870169 |
| 49 | negative regulation of growth of symbiont in host (GO:0044130) | 2.91536298 |
| 50 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.91536298 |
| 51 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.91536298 |
| 52 | regulation of growth of symbiont in host (GO:0044126) | 2.91536298 |
| 53 | B cell activation involved in immune response (GO:0002312) | 2.87146442 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 2.85835493 |
| 55 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.85164431 |
| 56 | regulation of tolerance induction (GO:0002643) | 2.85047349 |
| 57 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.84779832 |
| 58 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.84410210 |
| 59 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.84410210 |
| 60 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82422999 |
| 61 | regulation of skeletal muscle contraction (GO:0014819) | 2.82302753 |
| 62 | positive regulation of respiratory burst (GO:0060267) | 2.77686845 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77260569 |
| 64 | negative regulation of cell killing (GO:0031342) | 2.77260569 |
| 65 | negative regulation of protein oligomerization (GO:0032460) | 2.76533064 |
| 66 | regulation of memory T cell differentiation (GO:0043380) | 2.75982513 |
| 67 | neutrophil activation (GO:0042119) | 2.72764443 |
| 68 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.71692850 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 2.70224689 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.69917916 |
| 71 | negative regulation of exocytosis (GO:0045920) | 2.64877549 |
| 72 | alanine transport (GO:0032328) | 2.64306060 |
| 73 | pantothenate metabolic process (GO:0015939) | 2.63673006 |
| 74 | necroptotic process (GO:0070266) | 2.63598801 |
| 75 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.62802892 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 2.62550504 |
| 77 | B cell proliferation (GO:0042100) | 2.61484729 |
| 78 | positive regulation of cell cycle G1/S phase transition (GO:1902808) | 2.60072823 |
| 79 | nitric oxide mediated signal transduction (GO:0007263) | 2.56979424 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55586395 |
| 81 | positive regulation of DNA recombination (GO:0045911) | 2.54945703 |
| 82 | glycine transport (GO:0015816) | 2.54697965 |
| 83 | signal peptide processing (GO:0006465) | 2.53219085 |
| 84 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.52130273 |
| 85 | regulation of granulocyte differentiation (GO:0030852) | 2.51830163 |
| 86 | myeloid leukocyte mediated immunity (GO:0002444) | 2.51419246 |
| 87 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.51412186 |
| 88 | superoxide anion generation (GO:0042554) | 2.49485747 |
| 89 | cardiolipin metabolic process (GO:0032048) | 2.49155576 |
| 90 | regulation of mast cell activation (GO:0033003) | 2.47154863 |
| 91 | cellular response to dsRNA (GO:0071359) | 2.46251161 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.45360012 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.45360012 |
| 94 | regulation of lymphocyte migration (GO:2000401) | 2.45083265 |
| 95 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.40756054 |
| 96 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.40756054 |
| 97 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.40756054 |
| 98 | positive T cell selection (GO:0043368) | 2.40478602 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.40436029 |
| 100 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.40261970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.90512207 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01246131 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67867565 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.55506299 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51843819 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38544579 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.27587468 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.13866391 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.11382624 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07908548 |
| 11 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.06772147 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.02236158 |
| 13 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96619803 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.90264622 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89813720 |
| 16 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.79002808 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78530043 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77855681 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77286995 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74819228 |
| 21 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.72344496 |
| 22 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.71952950 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71907614 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68357550 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67707308 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.63791896 |
| 27 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.63485084 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.62621891 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62168928 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61196396 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56198873 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51164098 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49176322 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48338841 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47496643 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42171233 |
| 37 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.40748296 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40220701 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40147358 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38393530 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36055348 |
| 42 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32582832 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.31362577 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31043851 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30822947 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29766680 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29439466 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29037612 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.27128374 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27069622 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25922522 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24773224 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.24200653 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23821301 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23290581 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23224175 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23220256 |
| 58 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22945578 |
| 59 | GATA3_26560356_Chip-Seq_TH1_Human | 1.20406899 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19299607 |
| 61 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18263758 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17872335 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17834658 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15897636 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14277053 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12738190 |
| 67 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12697405 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11430046 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11264084 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10640922 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10169200 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09516578 |
| 73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07503155 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07388932 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05243365 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05184479 |
| 77 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04576518 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04508226 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03154074 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02630106 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02613711 |
| 82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01232694 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01221349 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00501453 |
| 85 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.00434448 |
| 86 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99904215 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99603055 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99075824 |
| 89 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.98658899 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97769280 |
| 91 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97753040 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.97130691 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96978267 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96783450 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.96411745 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95887491 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94441077 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93773150 |
| 99 | NFYB_21822215_ChIP-Seq_K562_Human | 0.93594238 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92688318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 6.88915529 |
| 2 | MP0002102_abnormal_ear_morphology | 5.21019365 |
| 3 | MP0000685_abnormal_immune_system | 4.02483944 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.51574289 |
| 5 | MP0003195_calcinosis | 3.39202077 |
| 6 | MP0002822_catalepsy | 3.34293281 |
| 7 | MP0001501_abnormal_sleep_pattern | 2.83726862 |
| 8 | MP0003724_increased_susceptibility_to | 2.68004312 |
| 9 | MP0009053_abnormal_anal_canal | 2.56805273 |
| 10 | MP0006082_CNS_inflammation | 2.28267805 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.14858042 |
| 12 | MP0003252_abnormal_bile_duct | 2.13868015 |
| 13 | MP0003436_decreased_susceptibility_to | 2.02891185 |
| 14 | MP0005387_immune_system_phenotype | 2.01422713 |
| 15 | MP0001790_abnormal_immune_system | 2.01422713 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.00108548 |
| 17 | MP0008877_abnormal_DNA_methylation | 1.96244220 |
| 18 | MP0005083_abnormal_biliary_tract | 1.86708425 |
| 19 | MP0005671_abnormal_response_to | 1.71718756 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 1.67513245 |
| 21 | MP0001800_abnormal_humoral_immune | 1.62802297 |
| 22 | MP0000383_abnormal_hair_follicle | 1.61072162 |
| 23 | MP0005025_abnormal_response_to | 1.57563305 |
| 24 | MP0009785_altered_susceptibility_to | 1.56494202 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.53561273 |
| 26 | MP0002723_abnormal_immune_serum | 1.49988842 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.49004494 |
| 28 | MP0008058_abnormal_DNA_repair | 1.47936506 |
| 29 | MP0003329_amyloid_beta_deposits | 1.43762717 |
| 30 | MP0001188_hyperpigmentation | 1.42060088 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.40935775 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.40049538 |
| 33 | MP0003943_abnormal_hepatobiliary_system | 1.38953112 |
| 34 | MP0003045_fibrosis | 1.38160807 |
| 35 | MP0008057_abnormal_DNA_replication | 1.37682604 |
| 36 | MP0002419_abnormal_innate_immunity | 1.34327241 |
| 37 | MP0001819_abnormal_immune_cell | 1.32191605 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.31990312 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.31829494 |
| 40 | MP0003718_maternal_effect | 1.31570125 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.31499886 |
| 42 | MP0002168_other_aberrant_phenotype | 1.30087103 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.29373614 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.26429555 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.26348983 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.24006542 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.23564408 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.21414147 |
| 49 | MP0000604_amyloidosis | 1.20479527 |
| 50 | MP0005395_other_phenotype | 1.16605061 |
| 51 | MP0000427_abnormal_hair_cycle | 1.13095168 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.13031748 |
| 53 | MP0009764_decreased_sensitivity_to | 1.12652111 |
| 54 | MP0003075_altered_response_to | 1.10884874 |
| 55 | MP0003011_delayed_dark_adaptation | 1.08202924 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 1.07626447 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.07531678 |
| 58 | MP0005360_urolithiasis | 1.07480611 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 1.06154939 |
| 60 | MP0003787_abnormal_imprinting | 1.04592769 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.03271720 |
| 62 | MP0000716_abnormal_immune_system | 1.00833669 |
| 63 | MP0000462_abnormal_digestive_system | 0.99920149 |
| 64 | MP0001764_abnormal_homeostasis | 0.98264697 |
| 65 | MP0008004_abnormal_stomach_pH | 0.94914754 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 0.94845189 |
| 67 | MP0002398_abnormal_bone_marrow | 0.92174315 |
| 68 | MP0005253_abnormal_eye_physiology | 0.91683556 |
| 69 | MP0005410_abnormal_fertilization | 0.86218165 |
| 70 | MP0008569_lethality_at_weaning | 0.83209847 |
| 71 | MP0002254_reproductive_system_inflammat | 0.82667132 |
| 72 | MP0001845_abnormal_inflammatory_respons | 0.81806502 |
| 73 | MP0009278_abnormal_bone_marrow | 0.78524509 |
| 74 | MP0002429_abnormal_blood_cell | 0.78395520 |
| 75 | MP0009763_increased_sensitivity_to | 0.77930108 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.75619974 |
| 77 | MP0002722_abnormal_immune_system | 0.75264578 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.74825679 |
| 79 | MP0003866_abnormal_defecation | 0.74454985 |
| 80 | MP0005670_abnormal_white_adipose | 0.74096750 |
| 81 | MP0003115_abnormal_respiratory_system | 0.71623582 |
| 82 | MP0001293_anophthalmia | 0.67737197 |
| 83 | MP0003638_abnormal_response/metabolism_ | 0.66808171 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.66238523 |
| 85 | MP0001919_abnormal_reproductive_system | 0.66012804 |
| 86 | MP0004742_abnormal_vestibular_system | 0.65706050 |
| 87 | MP0004885_abnormal_endolymph | 0.65215030 |
| 88 | MP0003633_abnormal_nervous_system | 0.65161078 |
| 89 | MP0004381_abnormal_hair_follicle | 0.63987022 |
| 90 | MP0008469_abnormal_protein_level | 0.62320756 |
| 91 | MP0001486_abnormal_startle_reflex | 0.61555790 |
| 92 | MP0000490_abnormal_crypts_of | 0.61289429 |
| 93 | MP0001968_abnormal_touch/_nociception | 0.60521561 |
| 94 | MP0000566_synostosis | 0.57495232 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.56120134 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.56120134 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.54806010 |
| 98 | MP0004858_abnormal_nervous_system | 0.52882711 |
| 99 | MP0008872_abnormal_physiological_respon | 0.52367170 |
| 100 | MP0005647_abnormal_sex_gland | 0.51289425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 9.22566560 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 8.74230206 |
| 3 | Amyotrophic lateral sclerosis (HP:0007354) | 6.36789044 |
| 4 | Increased IgM level (HP:0003496) | 5.74624432 |
| 5 | Tetraparesis (HP:0002273) | 4.48916539 |
| 6 | Delusions (HP:0000746) | 3.81823280 |
| 7 | Abnormality of T cell physiology (HP:0011840) | 3.72916184 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33376557 |
| 9 | Stomach cancer (HP:0012126) | 3.26543538 |
| 10 | Abnormality of incisor morphology (HP:0011063) | 3.20410908 |
| 11 | IgA deficiency (HP:0002720) | 3.19637553 |
| 12 | IgG deficiency (HP:0004315) | 3.16702976 |
| 13 | Myositis (HP:0100614) | 3.04405908 |
| 14 | Congenital stationary night blindness (HP:0007642) | 2.90412305 |
| 15 | Episodic fever (HP:0001954) | 2.85738631 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78841337 |
| 17 | Gingivitis (HP:0000230) | 2.74863888 |
| 18 | Impulsivity (HP:0100710) | 2.74405295 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70144347 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70144347 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.66579352 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 2.64941631 |
| 23 | Dyskinesia (HP:0100660) | 2.60258565 |
| 24 | Cerebellar dysplasia (HP:0007033) | 2.59233186 |
| 25 | Orchitis (HP:0100796) | 2.57877416 |
| 26 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.55201744 |
| 27 | Abnormality of T cells (HP:0002843) | 2.51747329 |
| 28 | Cerebral hypomyelination (HP:0006808) | 2.49378042 |
| 29 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.48172739 |
| 30 | Short 4th metacarpal (HP:0010044) | 2.48172739 |
| 31 | Recurrent skin infections (HP:0001581) | 2.46218819 |
| 32 | Gonadotropin excess (HP:0000837) | 2.44514527 |
| 33 | Pendular nystagmus (HP:0012043) | 2.43772728 |
| 34 | Growth hormone deficiency (HP:0000824) | 2.43541082 |
| 35 | Pustule (HP:0200039) | 2.30515157 |
| 36 | Methylmalonic acidemia (HP:0002912) | 2.29124256 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.26882781 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.26302542 |
| 39 | Recurrent abscess formation (HP:0002722) | 2.25422833 |
| 40 | Decreased central vision (HP:0007663) | 2.24123484 |
| 41 | Cone-rod dystrophy (HP:0000548) | 2.21803394 |
| 42 | Truncal obesity (HP:0001956) | 2.20731034 |
| 43 | Nephronophthisis (HP:0000090) | 2.17180929 |
| 44 | Upper motor neuron abnormality (HP:0002127) | 2.15041766 |
| 45 | Apathy (HP:0000741) | 2.14839853 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.14283558 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12348904 |
| 48 | Methylmalonic aciduria (HP:0012120) | 2.11792760 |
| 49 | Prostate neoplasm (HP:0100787) | 2.09522969 |
| 50 | Optic neuritis (HP:0100653) | 2.09411922 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.09411922 |
| 52 | Amyloidosis (HP:0011034) | 2.09222892 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08298978 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.06120306 |
| 55 | Malnutrition (HP:0004395) | 2.05913644 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.04201392 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.03279622 |
| 58 | Bilateral microphthalmos (HP:0007633) | 2.02027400 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.01447281 |
| 60 | Hypergammaglobulinemia (HP:0010702) | 2.01443473 |
| 61 | Narrow palate (HP:0000189) | 1.97945559 |
| 62 | Long toe (HP:0010511) | 1.97214942 |
| 63 | Abnormality of vision evoked potentials (HP:0000649) | 1.96746263 |
| 64 | Abnormality of the prostate (HP:0008775) | 1.92625564 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 1.92300500 |
| 66 | Progressive sensorineural hearing impairment (HP:0000408) | 1.90971413 |
| 67 | Chronic hepatic failure (HP:0100626) | 1.90138773 |
| 68 | Abnormality of midbrain morphology (HP:0002418) | 1.87251237 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 1.87251237 |
| 70 | Diminished motivation (HP:0000745) | 1.87033770 |
| 71 | Neutropenia (HP:0001875) | 1.86028580 |
| 72 | Poikilocytosis (HP:0004447) | 1.82475062 |
| 73 | Hypoglycemic seizures (HP:0002173) | 1.82446306 |
| 74 | Lymphopenia (HP:0001888) | 1.80492681 |
| 75 | Abnormal drinking behavior (HP:0030082) | 1.80345843 |
| 76 | Polydipsia (HP:0001959) | 1.80345843 |
| 77 | Alveolar cell carcinoma (HP:0006519) | 1.78827814 |
| 78 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77449549 |
| 79 | True hermaphroditism (HP:0010459) | 1.77372123 |
| 80 | Hypoplasia of the uterus (HP:0000013) | 1.77087804 |
| 81 | Constricted visual fields (HP:0001133) | 1.75722199 |
| 82 | Petechiae (HP:0000967) | 1.75591706 |
| 83 | Gingival bleeding (HP:0000225) | 1.73720156 |
| 84 | Enlarged kidneys (HP:0000105) | 1.73040511 |
| 85 | Pancreatic cysts (HP:0001737) | 1.71429800 |
| 86 | Type II lissencephaly (HP:0007260) | 1.70512407 |
| 87 | Lipid accumulation in hepatocytes (HP:0006561) | 1.70282166 |
| 88 | Chronic sinusitis (HP:0011109) | 1.69919119 |
| 89 | Severe visual impairment (HP:0001141) | 1.69010552 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.68064875 |
| 91 | Agitation (HP:0000713) | 1.67453030 |
| 92 | Colon cancer (HP:0003003) | 1.66938614 |
| 93 | Hand muscle atrophy (HP:0009130) | 1.66790235 |
| 94 | Abnormality of vitamin B metabolism (HP:0004340) | 1.66763471 |
| 95 | Abnormal neuron morphology (HP:0012757) | 1.66667684 |
| 96 | Abnormality of the motor neurons (HP:0002450) | 1.66667684 |
| 97 | Basal cell carcinoma (HP:0002671) | 1.62255056 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 1.62214678 |
| 99 | Epistaxis (HP:0000421) | 1.62115022 |
| 100 | Porencephaly (HP:0002132) | 1.61847050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 4.89387857 |
| 2 | ZAK | 3.88526199 |
| 3 | PBK | 2.40752508 |
| 4 | NUAK1 | 2.33490638 |
| 5 | PRKD2 | 2.31211151 |
| 6 | TYK2 | 2.28101924 |
| 7 | WNK3 | 2.19196555 |
| 8 | PASK | 1.99572404 |
| 9 | ADRBK2 | 1.87069396 |
| 10 | MAPK13 | 1.85386491 |
| 11 | PTK2B | 1.84117872 |
| 12 | DYRK3 | 1.83001666 |
| 13 | AKT3 | 1.74966100 |
| 14 | ACVR1B | 1.71638224 |
| 15 | RIPK4 | 1.69955459 |
| 16 | MAP3K6 | 1.69547684 |
| 17 | TNK2 | 1.68816008 |
| 18 | ERN1 | 1.65775052 |
| 19 | NTRK3 | 1.64153722 |
| 20 | BTK | 1.63843542 |
| 21 | GRK6 | 1.63466914 |
| 22 | BLK | 1.54271265 |
| 23 | MAP3K2 | 1.53264836 |
| 24 | FRK | 1.48015671 |
| 25 | LIMK1 | 1.45186531 |
| 26 | RPS6KA4 | 1.35445761 |
| 27 | MKNK1 | 1.33509335 |
| 28 | PKN1 | 1.31493011 |
| 29 | MAPKAPK3 | 1.27786169 |
| 30 | TXK | 1.27322192 |
| 31 | PRKCH | 1.24788764 |
| 32 | IRAK4 | 1.24186090 |
| 33 | IKBKE | 1.22395396 |
| 34 | MAP3K5 | 1.14731194 |
| 35 | BMPR1B | 1.13640514 |
| 36 | GRK5 | 1.06968999 |
| 37 | HCK | 1.02149913 |
| 38 | MELK | 1.02116206 |
| 39 | TESK1 | 1.01279988 |
| 40 | MAPKAPK5 | 0.95105232 |
| 41 | IKBKB | 0.91344826 |
| 42 | GRK1 | 0.91062796 |
| 43 | TEC | 0.90742470 |
| 44 | ERBB3 | 0.87740533 |
| 45 | ZAP70 | 0.85496672 |
| 46 | KIT | 0.84617614 |
| 47 | CLK1 | 0.84608099 |
| 48 | DAPK2 | 0.84594763 |
| 49 | MAP3K4 | 0.84319491 |
| 50 | ABL2 | 0.83976741 |
| 51 | SYK | 0.82623801 |
| 52 | MAPK11 | 0.82237404 |
| 53 | SIK3 | 0.81307897 |
| 54 | PAK3 | 0.80181611 |
| 55 | RPS6KA6 | 0.79893303 |
| 56 | TRPM7 | 0.79477687 |
| 57 | ADRBK1 | 0.78622407 |
| 58 | PRKG2 | 0.77128167 |
| 59 | RET | 0.75435248 |
| 60 | GRK7 | 0.73544389 |
| 61 | MAP2K2 | 0.71250046 |
| 62 | DMPK | 0.70944574 |
| 63 | PRKCQ | 0.69775795 |
| 64 | JAK2 | 0.68494542 |
| 65 | BRD4 | 0.67523563 |
| 66 | PDK1 | 0.66324354 |
| 67 | HIPK2 | 0.65114996 |
| 68 | CAMK1 | 0.64743885 |
| 69 | OXSR1 | 0.64562500 |
| 70 | RPS6KC1 | 0.64021387 |
| 71 | RPS6KL1 | 0.64021387 |
| 72 | MAP2K3 | 0.63684497 |
| 73 | LYN | 0.60738479 |
| 74 | RAF1 | 0.60497451 |
| 75 | SRPK1 | 0.59330686 |
| 76 | TRIM28 | 0.57213432 |
| 77 | JAK1 | 0.56783181 |
| 78 | SGK2 | 0.55430815 |
| 79 | MAP4K1 | 0.55420658 |
| 80 | MAP2K6 | 0.53913657 |
| 81 | LCK | 0.53262681 |
| 82 | PRKCE | 0.52964653 |
| 83 | RPS6KB2 | 0.52145013 |
| 84 | MAP2K4 | 0.48959542 |
| 85 | PLK2 | 0.48705656 |
| 86 | CSF1R | 0.48383461 |
| 87 | IRAK1 | 0.48132646 |
| 88 | TAOK3 | 0.46033941 |
| 89 | MKNK2 | 0.44255403 |
| 90 | CSK | 0.42823967 |
| 91 | BCKDK | 0.40867514 |
| 92 | STK39 | 0.39333707 |
| 93 | PDPK1 | 0.39270145 |
| 94 | PDK2 | 0.39171289 |
| 95 | DYRK2 | 0.38974987 |
| 96 | ICK | 0.37630633 |
| 97 | TGFBR2 | 0.37091084 |
| 98 | TAOK1 | 0.36766587 |
| 99 | RPS6KA5 | 0.36618876 |
| 100 | FES | 0.35964179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.00068954 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.56232038 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.46550281 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.31583410 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.07291628 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.02123369 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.61440731 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.41593290 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.23288012 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.15313948 |
| 11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.97853117 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.94631745 |
| 13 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.92817089 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.70759055 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70208201 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66541994 |
| 17 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.63296111 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52109037 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44815449 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41162047 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40846748 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38686585 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36494122 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32891988 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32831992 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29460604 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.27756858 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22091055 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17825274 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17247700 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14350294 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.13764686 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13114614 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12783156 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.09918959 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06738216 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05265766 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04834682 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02576203 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.00996274 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99838050 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96718091 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95941525 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95317862 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93796203 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90553949 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89545547 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86511642 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.84875952 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84532101 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.84224210 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83738904 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83628233 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83277513 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80616697 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78110119 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77092596 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74913052 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.73663243 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71860069 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69289218 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66485394 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 0.64245776 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61437071 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60565464 |
| 66 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59023052 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56496215 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56177953 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55555100 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51802204 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51127603 |
| 72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49307133 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.48740951 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46904790 |
| 75 | Protein export_Homo sapiens_hsa03060 | 0.45148410 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44502357 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44023735 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43276504 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.42700943 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39092639 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.37516943 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37338131 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.35535156 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35438339 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.32891088 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.31523118 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31210943 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30877637 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28893596 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28529951 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28510588 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27415471 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26133507 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25890991 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25632090 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | 0.25259904 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24676324 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23223724 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23132120 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.22849337 |

